Women who are “larks,” functioning better at the beginning of the day than the end of the day, have a […] By combining data on individuals’ lifetime sun exposure and their genetics, researchers can generate improved predictions of their risk of […] A world-first study led by University of Sydney has found that Australians aged 18-40 years who were regular users of […] An international research team led by Helmholtz Zentrum München, Technical University of Munich and the University of Edinburgh has used […] A new study in the Journal of the National Cancer Institute, published by Oxford University Press, indicates that recent-onset type […] Researchers at Ruhr-Universität Bochum have deployed a novel infrared (IR) microscope with quantum cascade lasers in order to analyse tissue […] Do metastatic cancer tumors “break bad” or are they “born bad”? This question is an essential mystery in cancer early […] Some 80,000 Americans will be diagnosed with a brain tumor this year according to the American Brain Tumor Association. Many […] A new type of cancer vaccine has yielded promising results in an initial clinical trial conducted at the Perelman School […] Matching unique genetic information from cancer patients’ tumors with treatment options — an emerging area of precision medicine efforts — […]Ovarian Cancer
Women who are ‘larks’ have a lower risk of developing breast cancer: Analyses of genetic variants show the effect of sleep on breast cancer risk
Combining genetic and sun exposure data improves skin cancer risk estimates
Sunscreen reduces melanoma risk by 40 per cent in young people
New insight into the maturation of miRNAs
Diabetes may be an early manifestation of pancreatic cancer
Label-free method for rapid cancer diagnosis: As fast as traditional methods, the so-called IR imaging offers several additional advantages
Deadly cancers show early, detectable differences from benign tumors: Small study in colorectal tumors distinguishes those that are ‘born bad’
Doctors may soon be able to see a brain tumor burned away in real time
Personalized tumor vaccine shows promise in pilot trial: Vaccine against patients’ own tumors triggers a broad response, and induced five-year remission in one patient with advanced ovarian cancer
Machine learning finds tumor gene variants and sensitivity to drugs in The Cancer Genome Atlas
Copyright © 2025